EC grants expanded approval for Amgen’s BLINCYTO in pediatric acute lymphoblastic leukemia treatment

In a significant development for pediatric oncology, the European Commission (EC) has approved an expanded indication for Amgen’s BLINCYTO (blinatumomab) as a monotherapy treatment for ... Read More